nadp has been researched along with Hematologic Malignancies in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fukushima, T; Imamura, M; Maeda, S; Masuzaki, H; Matsushita, M; Morishima, S; Nakachi, S; Nishi, Y; Nomura, I; Okamoto, S; Tamaki, K; Tanaka, Y; Tomihama, M; Tsutsui, M | 1 |
1 other study(ies) available for nadp and Hematologic Malignancies
| Article | Year |
|---|---|
Impact of anti-diabetic sodium-glucose cotransporter 2 inhibitors on tumor growth of intractable hematological malignancy in humans.
Topics: Adenosine Triphosphate; Hematologic Neoplasms; Humans; NADP; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors | 2022 |